Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

antimicrobial * areas 13

12th World AIDS Conference

SKeyword

Abstract

Keyword

Abstract
ic or topical antibiotics,, antifungal and anti-protozo 22207
tiretroviral therapy and antineoplastic chemotherapy (CT) in AID 60487
d patients in Argentina/ Antioxidants enzymes level in human blo 42368
users/Dietary intake of antioxidants and body composition in a co 42345
c HIV positive subjects/ Antiphospholipid antibodies (APL) and n 32218
mbination therapy with antiprotease inhibitors among HIV-infecte 32359
s in HIV patients under therapy/Comparison of a P 42192
with HAART including 6 months after the end of che 60510
ected patients receiving antiretrovial therapy: DDI/delaviridine (DL 31108
AQ) salvage therapy in antiretroviral-experienced patients/Rito 12310
on with AZT and 3TC in antiretroviral-naive HIV-1 infected patient 12301
4 and RNA response in patients with very adv 12363
tiretroviral treatment in patients with very adv 12444
n a US military cohort of recent seroconvertor 13215
vir as a triple therapy in patients: Results at 7 22401
minal HIV-1 viral load in Brazilian subjects/Hi 23399
-1 to a recently infected man: The UCSF optio 32288
gauge effectiveness of antiretrovirals /HIV-RNA and CD4+ declin 12127
ferent combinations of (AZT + ddl vs. AZT + 3TC + 12200
f people with HIV/AIDS therapies naives/Patient p 12452
ssai Cinq-a-Zero): Five combined during 6 months 41194
compared to other HIV /Nevirapine has excellent b 60086
ferent combinations of (AZT + 3TC vs. AZT + ddl) 60657
atients on highly active antirretroviral treatment (HAART)/Nonpr 22271
mary HIV-1 isolates by antisera induced upon immunization with 550*/21194
etreated HIV-patients: Antiviral effect and safety in an ongoing st 12226
s: The Quadri-96 Trial/ effect of a four-drug combination i 22397
with both HIV and HCV/ effect of interferon a-2a (IFNa) in 32103
opulation-based study/ effect of AZT versus d4T in combi 42169
onate release nelfinavir/ benefits of compassionate releas 60427
ance of prophylaxis and antiviral treatment/HIV patients' survival i 12111
patients receiving triple therapy/Suppression of viremia a 12191
onavir may have better efficacy than either ritonavir or ind 126*/12221
ficacy of combination therapy with ZDV 200 mg TID plu 12240
patients with extensive experience/Effect of nelfinavir/in 12329
inhibitors (PIs)/In vitro activity and pharmacokinetic (PK) 12339
antiretroviral and other therapies on the incidence of Kap 13241
hen use of highly active therapy (HAART) became preval 13307
s may have synergistic effects in patients - Based on in vi 22350
ction/Effect of the new therapy in the quality of life, psych 22392
avir and correlation with activity/Pharmacokinetic interacti 22404
nce/Impact of the new therapies in persons with AIDS an 22445
ies/Sustained release implants for the prevention of mat 23267
ve mothers undergoing therapy/The trophoblastic epithel 23286
nfectivity: The effect of treatment on the shedding of cell- 23392
is/Recent advances in therapy (ARV) for HIV can result i 24136
after 18 months of new therapy: The Parisian experience 24154
ypic drug resistance to nucleoside inhibitors in short-time 233*/32282
genotypic predictors of response to saquinavir (SQV)/rito 229*/32287
pretreated with multiple drugs/Protease inhibitor therapy i 32440
S cities/Prevalence of medication use in a probability sa 33169
ar pharmacology of the agents PMPA and PMEA in vitro 554*/41175
CD38 stimulation exerts effects and modulates CXCR-4 e 41234
gene therapy based on properties of IFN-/: Efficiency in t 41248
sfert/In vitro and in vivo effect of human interferon-P indu 41250
harmacokinetics and activity in phase I/11 trials/Relatio 42266
portive supplement with drugs/L-carnitine and magnesiu 42384
ted on the basis of their activity/Case reports of potential 42388
t: Consequence of new strategies/Changing patterns of 42440
vir (NFV) in patients on combination therapy with a HIV-1 60181
y: A new approach into treatment, 1. In vitro activity/Multi 60205
storation in associated treatment ZDV-DDC (Retrovir-Hi 60235
y/Preliminary results of effect of double and triple drug co 60252
ses about adherence to therapies/Comparison between 60481
plasma viremia despite discontinuation for 14 months/Lo 61000
r/Susceptibility profile ( AntivirogramTM ) of 945 clinical HIV-1 isolat 41226
V positive patients with antral gastritis/Helicobacter pylori infectio 32122
HIV+ pregnant women/ Antretroviral use and adherence in a coho 32329
the University Hospital Antwerp: Compliance with universal preca 62*/22459
the University Hospital, Belgium/Direct nursing time wit 22463
the University Hospital, Belgium/Degree of satisfaction 42219
dolescents/Life stress, anxiety, depression, and coping among HI 24224
home test kits/HIV test: Public health vs. home test kits/H 60343
anism of HIV infectivity/ AOP-RANTES inhibits CCR5 recycling -A 58*/11102
y of aminooxypentane ( AOP )-RANTES as inhibitor of HIV-1 infecti 59*/41231

al hyper-pigmentation ( ) in HIV +ve patients: A prominent, fre 60125
of epidemic of AIDS on AP-HP, a large hospital organisation/Impa 43565
Omega and Polyatomic Apheresis (WDDS treatment)/Ethics in HI 474*/44140
e primary HIV infection ( APHI ): A cohort description/Acute primary 12192
n molecules in recurrent aphthous ulcers in HIV-1 (+) and HIV-1 (-) 32250

yte subsets in recurrent ulcers in HIV-1+ and HIV-1 - pat 60502
line for the treatment of aphtous ulcers in HIV patients/Pentoxifylli 60371
associated pure red cell aplasia (PRCA)/Lamivudine-associated p 32142
s violations in Asia: The APN + human rights initiative/Training HIV 535*/44133
homa/Proliferation and apoptosis-related gene expression in exp 11216
se of SIVmac infection/ Apoptosis of lymphocytes and Fas Ag exp 11227
enic for HIV-1 Vpr/T cell apoptosis in mice transgenic for HIV-1 Vpr 11142
in induces CD4+ T-cell through functional upregulation 11145
leukin-2 synthesis and in fresh or cultured lymphocyte 12180
) on T-cell function and in early HIV infection/Effect of d 12200
activation/HIV-Induced of renal tubular epithelial cells i 21137
protein p53 and inhibits /HIV-1 Nef associates with the t 21148
nce of interleukin-15 on and proliferation of T lymphocyt 280*/21162
ecrease in lymphocyte in association with decrease in 21163
number/Fas mediated of CD4 T cells from HIV+ patien 21165
Fas activation mediate in HIV-gpl20-treated CD4+ T c 21166
)/HHV-8, proliferation, and ploidy in epidemic (AKS), e 620*/22282
cted individuals induce of primary neurons/Inflammato 32200
therapy/Modification of during combination therapy/M 42184
ytokine production and in asymptomatic HIV infection/ 60657
etween spontaneous and plasmatic viremia in HIV inf 60975
n HIV-1-infected cells/ Apoptotic activity of nitric oxide in HIV-1-in 60255
nd the percentage of apoptotic cells in HIV infected patients/Int 41235
ol of neuropathy, loss of appetite,skin infection in HIV/AIDS patient 60259
tion of disease status to appointment-keeping /HIV out-patient ad 42453
y from drug abuse, and appointment adherence are associated w 60408
dividuals at workplace/ Apprehension to care HIV infected individ 24308
ress and hair dresser's apprentices on sexually transmissible dis 60756
n HIV infected patients, Aquitaine (France), 1988-97/Influence of 22360
efining diagnosis in the cohort, France, 1985-1997/Pre 42342
r AIDS diagnosis in the cohort, France, 1985-1997/We 42360
-acquired HIV infection: (France), 1985-1997/Tempora 60400
y blood donors in Saudi Arabia (1985-1997)/Incidence of HIV infe 42120
sian recruiters to Saudi /Seroepidemiological prevalence o 42139
V transmission among Arabian prisoners of northern Italy using p 33560
th HIV/AIDS in Mexico, Arbol de la Vida Enfermos en Superaci6n, 34335
cases/Treat AIDS and ARC with Chinese traditional medicine "ext 41238
unoassay on the Abbott ArchitectTM i2000 analyzer/Performance o 41115
viral load and lymphoid architecture /Rectal sno-strips and biopsi 42147
ssing medical care: An archival review/Substance use profiles of i 43239

ashington metropolitan area /Use of zidovudine to reduce the risk o
IDS in poverty stricken /Playing again: Psychology and affect
ality in a urban and rural of Togo (Lome and Kpele-adeta)/Sec
ers in the Manila harbor /Implementing an STD/AIDS educatio
umbai Metro's redlight /A comprehensive health care deliver
ucation in metropolitan and inner cities in Rio de Janeiro Stat
on low HIV prevalence: A pilot study/An HIV and sexual healt
miology of HIV in a rural /A pilot study of the epidemiology of H
ur in CSWs in Red Ligh, Multan/Change of sex behaviour in
in a poor AIDS stricken /"Dear Mr. Death": Community berea
ophiliacs with HIV in an with low infection rate in IDUs and sex
he Tokyo Metropolitan /Potential for an HIV epidemic and pre
rogram in highway rural of Nepal/AIDS prevention program in
mong SWs in a red light /STD intervention among SWs in a re
ntion in a Ugandan rural /Interference of traditional customs wi
g interventions in a rural /Community counselling interventions
ug treatment in Seattle drug injectors/The association betwe
IV/High transmission intervention project in northern Tanza
ledge of AIDS in a rural of Bangladesh/Effects of AIDS aware
pie in an inner London /Community intervention program of s
or female orphans in an with high HIV seroprevalence/A resid
ical perspective of Bay young positives/The changing needs
nal healers in an urban of Cameroon/Management of STD a
urban marginal precary of Guatemala/The STD/HIV/AIDS cli
nities; rural vs. sanitary /Model development on community a
n the Washington DC /Changes in knowledge and attitudes
ct of HIV/AIDS in a rural /An intergrated approach to reduce th
nd prostitutes in Madrid (1986-1998)/Evolution of HIV seropr
service in metropolitan of Rome/Characteristics of AIDS pati
nant women in the Paris, France/HIV screening practices tow
n the Washington, DC /Techniques to train recent Latin Ame
nfection in Hiroshima,Japan/Isolation and analysis of viral
n rates of testing in an of low prevalence/Screening for HIV i
infection control/Facial infection control/Facial
regnant women in rural and urban area/Comparison of preval
om a low HIV incidence of Spain/Seroprevalence of HIV infec
an African KS endemic /Immune status of HIV-infected patien
mothers leaving in rural against STD/AIDS in Cameroon/Mob
ome women from slum areas in Rio de Janeiro, Brazil/Evaluating
th men in seven urban, USA/Prevalence and predictors of

12157
13377
13395
13441
13491
23127
23522
23559
23570
24246
32437
33109
33117
33249
33311
33314
33387
33423
33477
33531
34143
34246
42372
43202
43207
43413
60075
60315
60439
60500
60531
60586
60596
60664
60874
60944
60970
60989
13425
23139